Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NEUROprotection Via optimizINg Cerebral Blood Flow afTer cArdiaC arresT (NEURO-INTACT) Study

NCT05679739 is registered in ClinicalTrials.gov with National University Hospital, Singapore as lead sponsor.

NCT NCT05679739
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05679739 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NEUROprotection Via optimizINg Cerebral Blood Flow afTer cArdiaC arresT (NEURO-INTACT) Study
Lead sponsor
National University Hospital, Singapore
Phase
Not applicable
Overall status
Recruiting
Start date
August 29, 2023
Completion date
August 31, 2026
Enrollment
49 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

out-of-hospital cardiac arrest (ohca)